The Measure of Plasma Concentrations Is Crucial in Managing Dabigatran Treatment in Non-Valvular Atrial Fibrillation

被引：0
|
作者：
Iosub, Diana [1 ]
Trotti, Rosa [2 ]
Piovella, Franco [2 ]
机构：
[1] Fdn IRCCS Policlin San Matteo, Pavia, Italy
[2] Fdn IRCCS Ist Neurol Nazl Casimiro Mondino, Pavia, Italy
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Medication adherence to rivaroxaban and dabigatran in patients with non-valvular atrial fibrillation: a meta-analysis
    Ashley Prentice
    Irene Ruiz
    Erin R. Weeda
    Journal of Thrombosis and Thrombolysis, 2020, 49 : 360 - 364
  • [42] Evaluation of Extended-Interval Dabigatran Dosing in Older Patients With Non-Valvular Atrial Fibrillation
    Ni, Lianfang
    Chen, Xiahuan
    Liu, Meilin
    Fan, Yan
    Fu, Zhifang
    Sun, Dan
    Zhao, Zhijie
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2021, 26 (04) : 359 - 364
  • [43] Non-valvular atrial fibrillation and stroke prevention
    Hankey, GJ
    MEDICAL JOURNAL OF AUSTRALIA, 2001, 174 (05) : 234 - 239
  • [44] Echocardiographic predictors of non-valvular atrial fibrillation
    David, C
    Almeida, A
    Marques, P
    Oliveira, EI
    Rodrigues, S
    Vagueiro, MC
    EUROPEAN HEART JOURNAL, 2003, 24 : 388 - 388
  • [45] Newer Anticoagulants for Non-Valvular Atrial Fibrillation
    Harburger, Joseph M.
    Aronow, Wilbert S.
    PHARMACEUTICALS, 2012, 5 (05) : 469 - 480
  • [46] COST-EFFECTIVENESS OF DABIGATRAN FOR THE PREVENTION OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN AUSTRALIA
    Tilden, D.
    Germanos, P.
    Gordon, J.
    Tocchini, L.
    Monz, B.
    VALUE IN HEALTH, 2011, 14 (07) : A375 - A375
  • [47] Influence of PAR-1 in patients with non-valvular atrial fibrillation: The antiplatelet effect of dabigatran
    Oi, Kiyotaka
    Shimizu, Mie
    Natori, Tatsunori
    Tsuda, Keisuke
    Yoshida, Makiko
    Kamada, Asami
    Ishigaku, Yoko
    Narumi, Shinsuke
    Oura, Kazumasa
    Maeda, Tetsuya
    Terayama, Yasuo
    THROMBOSIS RESEARCH, 2021, 201 : 123 - 130
  • [48] Medication adherence to rivaroxaban and dabigatran in patients with non-valvular atrial fibrillation: a meta-analysis
    Prentice, Ashley
    Ruiz, Irene
    Weeda, Erin R.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 49 (03) : 360 - 364
  • [49] Distribution of thromboembolism in valvular versus non-valvular atrial fibrillation
    Blustin, Jodi M.
    McBane, Robert D.
    Ketha, Siva S.
    Wysokinski, Waldemar E.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2014, 12 (10) : 1129 - 1132
  • [50] DISTRIBUTION OF THROMBOEMBOLISM IN VALVULAR COMPARED TO NON-VALVULAR ATRIAL FIBRILLATION
    Ketha, Siva S.
    McBane, Robert
    Grill, Diane
    Mehta, Ramila
    Wysokinski, Waldemar
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A368 - A368
12345